Simon Panton Buys 500,000 Shares of Resonance Health Limited (ASX:RHT) Stock

Resonance Health Limited (ASX:RHT) insider Simon Panton acquired 500,000 shares of the company’s stock in a transaction that occurred on Monday, April 8th. The shares were acquired at an average price of A$0.07 ($0.04) per share, with a total value of A$32,500.00 ($21,523.18).

Resonance Health Price Performance

The company has a quick ratio of 9.76, a current ratio of 8.25 and a debt-to-equity ratio of 3.26.

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report.